ILF2P2

Across TCGA pan-cancer cohorts, ILF2P2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ILF2P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ILF2P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ILF2P2 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

BRCA, KICH, and COAD are the cancer types where ILF2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ILF2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.009	.041	4	view →
KICH	All	All	−0.020	.008	3	view →
COAD	All	II,III,IV	+0.017	.036	2	view →
THCA	Female	All	−0.060	.033	1	view →
KIRC	Female	All	+0.011	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ILF2P2–BRCA

Open the BRCA breakdown →